Atypical nested 22q11.2 duplications between LCR22B and LCR22D are associated with neurodevelopmental phenotypes including autism spectrum disorder with incomplete penetrance by Woodward, K. et al.
Mol Genet Genomic Med. 2019;7:e507.    |  1 of 17
https://doi.org/10.1002/mgg3.507
wileyonlinelibrary.com/journal/mgg3
Received: 11 December 2017 | Revised: 18 September 2018 | Accepted: 10 October 2018
DOI: 10.1002/mgg3.507
O R I G I N A L  A R T I C L E
Atypical nested 22q11.2 duplications between LCR22B and 
LCR22D are associated with neurodevelopmental phenotypes 
including autism spectrum disorder with incomplete penetrance
Karen J. Woodward1,2 | Julie Stampalia1 | Hannah Vanyai3,4 | Hashika Rijhumal1 |  
Kim Potts1 | Fiona Taylor1 | Joanne Peverall1 | Tanya Grumball1 |  
Soruba Sivamoorthy1 | Hamid Alinejad-Rokny3,4 | John Wray5 | Andrew Whitehouse5 |  
Lakshmi Nagarajan6,7 | Jacqueline Scurlock8 | Sabine Afchani9,10 |  
Matthew Edwards11 | Ashleigh Murch1,2 | John Beilby1,2 | Gareth Baynam5,7,12,13,14,15,16 |  
Cathy Kiraly-Borri6,12 | Fiona McKenzie12,7 | Julian I. T. Heng3,4,17
1Diagnostic Genomics, PathWest Laboratory Medicine, Perth, Western Australia, Australia
2School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia
3The Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia, Australia
4Centre for Medical Research, University of Western Australia, Nedlands, Western Australia, Australia
5Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia
6Children’s Neuroscience Service, Princess Margaret Hospital, Subiaco, Western Australia, Australia
7School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia
8Rural Health West, Esperance, Western Australia, Australia
9Lockridge Child Development Centre, Lockridge, Western Australia, Australia
10State Child Development Centre, West Perth, Western Australia, Australia
11School of Medicine, Western Sydney University, Penrith South DC, New South Wales, Australia
12Genetic Services of Western Australia, Perth, Western Australia, Australia
13Department of Health, Office of Population Health Genomics, Public Health and Clinical Services Division, Perth, Western Australia, Australia
14Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia
15Western Australian Register of Developmental Anomalies, Perth, Western Australia, Australia
16Spatial Sciences, Science and Engineering, Curtin University, Perth, Western Australia, Australia
17Curtin Health Innovation Research Institute and Sarich Neuroscience Institute, Curtin University, Crawley, Western Australia, Australia
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Correspondence
Karen Woodward, Diagnostic Genomics, 
PathWest laboratory Medicine, Perth, 
Western Australia, Australia.
Email: karen.woodward2@health.wa.gov.au
and
Julian Ik-Tsen Heng, The Harry Perkins 
Institute of Medical Research, QEII Medical 
Centre, Nedlands, Western Australia, 
Abstract
Background: Chromosome 22q11.2 is susceptible to genomic rearrangements and 
the most frequently reported involve deletions and duplications between low copy 
repeats LCR22A to LCR22D. Atypical nested deletions and duplications are rarer 
and can provide a valuable opportunity to investigate the dosage effects of a smaller 
subset of genes within the 22q11.2 genomic disorder region.
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1 |  INTRODUCTION
Chromosome 22q11.2 contains eight highly homologous 
low copy repeat (LCR) sequences that are named LCR22A 
to LCR22H and that predispose the region to recurrent dele-
tions and duplications by non allelic homologous recombina-
tion (NAHR) (Edelmann, Pandita, & Morrow, 1999; Shaikh, 
Kurahashi, & Emanuel, 2001; Shaikh et al., 2000). The four 
proximal LCRs, LCR22A to LCR22D (A- D), are implicated 
in 22q11.2 deletion syndrome (also known as DiGeorge/
velo- cardio- facial syndrome (DG/VCFS) (OMIM:188400 
and OMIM:192430, respectively) and the reciprocal 22q11.2 
duplication syndrome (OMIM:608363). The four distal 
LCRs, LCR22E to LCR22H (E- H), are smaller in size and 
are involved in the less frequent distal 22q11.2 deletions and 
duplications (OMIM:611867) (Mikhail et al., 2014; Wincent 
et al., 2010).
The typical 3 Mb deletion causing 22q11.2 deletion syn-
drome occurs between LCR22A and LCR22D and is one of 
the most frequent pathogenic microdeletions in humans with 
an incidence of around 1/4,000 live births (Devriendt, Fryns, 
Mortier, van Thienen, & Keymolen, 1998). Clinical features 
in patients with typical 22q11.2 deletions are variable and 
usually include congenital heart defects (mostly conotruncal 
anomalies), characteristic facial features, immune deficiency, 
transient neonatal hypocalcaemia, palatal abnormali-
ties (particularly velopharyngeal insufficiency), postnatal 
growth restriction, hypotonia, developmental delay, intel-
lectual disability, autism spectrum disorder, and behavioral 
problems (McDonald- McGinn, Emanuel, & Zackai, 1993). 
Approximately 8%–10% of individuals with 22q11.2 deletion 
syndrome have a smaller nested 1.5 Mb deletion, proximally 
located between LCR22A and LCR22B (Burnside, 2015). 
The phenotypes of individuals with the 3 Mb typically deleted 
region (TDR) (A- D) and the 1.5 Mb deletion (A- B) are clini-
cally indistinguishable (Carlson et al., 1997), and haploinsuf-
ficiency of critical genes, including TBX1 (OMIM:60254), is 
the proposed mechanism (McDonald- McGinn et al., 1993).
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Methods: We describe thirteen individuals from six families, each with atypical 
nested duplications within the central 22q11.2 region between LCR22B and LCR22D. 
We then compared the molecular and clinical data for patients from this study and the 
few reported atypical duplication cases, to the cases with larger typical duplications 
between LCR22A and LCR22D. Further, we analyzed genes with the nested region 
to identify candidates highly enriched in human brain tissues.
Results: We observed that atypical nested duplications are heterogeneous in size, 
often familial, and associated with incomplete penetrance and highly variable clinical 
expressivity. We found that the nested atypical duplications are a possible risk factor 
for neurodevelopmental phenotypes, particularly for autism spectrum disorder 
(ASD), speech and language delay, and behavioral abnormalities. In addition, we 
analyzed genes within the nested region between LCR22B and LCR22D to identify 
nine genes (ZNF74, KLHL22, MED15, PI4KA, SERPIND1, CRKL, AIFM3, SLC7A4, 
and BCRP2) with enriched expression in the nervous system, each with unique spa-
tiotemporal patterns in fetal and adult brain tissues. Interestingly, PI4KA is promi-
nently expressed in the brain, and this gene is included either partially or completely 
in all of our subjects.
Conclusion: Our findings confirm variable expressivity and incomplete penetrance 
for atypical nested 22q11.2 duplications and identify genes such as PI4KA to be di-
rectly relevant to brain development and disorder. We conclude that further work is 
needed to elucidate the basis of variable neurodevelopmental phenotypes and to ex-
clude the presence of a second disorder. Our findings contribute to the genotype–phe-
notype data for atypical nested 22q11.2 duplications, with implications for genetic 
counseling.
K E Y W O R D S
22q11.2, atypical, autism spectrum disorder, central 22q11.2, duplication, LCR22B to LCR22D
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Individuals with typical 22q11.2 duplications present with 
significant inter- and intrafamilial variability, with pheno-
types ranging from normal or with a mild learning disability 
to severe congenital malformations (Ensenauer et al., 2003; 
de La Rochebrochard et al., 2006; Portnoi, 2009; Portnoi 
et al., 2005). Clinical features can also include more signif-
icant degrees of intellectual disability, delayed psychomotor 
development, growth retardation, and muscular hypotonia 
(Wentzel, Fernstrom, Ohrner, Anneren, & Thuresson, 2008). 
Autism spectrum disorder is also a feature of 22q11.2 dupli-
cation carriers, with an estimated rate of 14%–25% (Clements 
et al., 2017; Wenger et al., 2016). Patients diagnosed with the 
typical 3 Mb duplication, or the nested 1.5 Mb duplication, 
show no apparent correlation between duplication size and 
phenotype (Van Campenhout et al., 2012). Furthermore, in 
contrast to the deletions that are mostly de novo in origin, the 
majority of duplications are inherited from a mildly affected 
or clinically normal parent (Clements et al., 2017; Ou et al., 
2008; Van Campenhout et al., 2012; Wentzel et al., 2008).
Although 22q11.2 deletions and duplications are reciprocal 
rearrangements and predicted to occur at the same frequency, 
the number of duplication cases reported in the literature is 
considerably less and this is likely due to their milder clinical 
effect (Portnoi, 2009). A recent case- cohort study in a Danish 
population found that although the prevalence of 22q11.2 
 deletion was within the expected range of approximately 1 in 
4,000, the prevalence of 22q11.2 duplications in the population 
was actually more than twice this number (1 in 1,606) (Olsen 
et al., 2018). The prevalence of both deletions and duplications 
was higher among individuals with a neuropsychiatric or de-
velopmental disorder than unaffected individuals. However, 
the overall prevalence of neuropsychiatric disorders was higher 
in duplication carriers compared with deletion carriers (Olsen 
et al., 2018).
To date, many individuals have been described with 
atypical nested 22q11.2 deletions between LCR22B and 
LCR22D (Clements et al., 2017; Rump et al., 2014; Wentzel 
et al., 2008). In contrast, very few cases with atypical nested 
22q11.2 duplications have been reported (Clements et al., 
2017; Diehl, Mu, Batista, & Gunay- Aygun, 2015; Fan et al., 
2007; Fernandez et al., 2009; Pebrel- Richard et al., 2012; 
Tucker et al., 2011, 2014). Here, we describe 13 individuals 
from six families with atypical nested 22q11.2 duplications 
between LCR22B and LCR22D. We provide molecular and 
clinical data for each individual and compare this informa-
tion to the previously reported atypical and typical cases. The 
number of atypical nested duplication cases is very limited; 
however, these rare individuals may be able to provide in-
sights into the importance of individual genes within this ge-
nomic region and their potential phenotypic contribution. In 
addition, we undertake gene expression analysis to identify 
candidate genes within the region LCR22B to LCR22D which 
are enriched in the brain. Among several candidates, PI4KA 
(OMIM:600286) is a gene highly expressed in fetal and brain 
tissues, and is disrupted either partially or completely in our 
subjects. Taken together, our study reinforces varied clinical 
presentation and neurodevelopmental phenotypes associated 
with atypical nested 22q11.2 duplications and is consistent 
with the notion that such duplications represent a risk factor 
for neurocognitive traits including ASD.
2 |  MATERIALS AND METHODS
2.1 | Ethical compliance
Informed consent was obtained for this study. The parents of 
child- aged patients gave written informed consent to publish 
clinical information and photographs.
2.2 | Clinical diagnosis
Individuals in the study were assessed through multiple 
clinical services and were ascertained to have various 
combinations of clinical features including developmental 
delay, intellectual disability, autism spectrum disorder, or 
multiple congenital anomalies. A standardized procedure 
for the diagnosis of ASDs and eligibility for Government- 
supported therapy provision was applied (Glasson et al., 
2008) and described briefly here. For children younger 
than 12 years of age, the diagnostic assessment is per-
formed by a team of three independent health profession-
als (pediatrician or psychiatrist, psychologist, and speech/
language pathologist). For adolescents (12–17 years) and 
adults, an assessment must be carried out by a clinical psy-
chologist, a pediatrician (for adolescents) and/or a psychia-
trist, with the inclusion of a formalized assessment by a 
speech- language pathologist as needed. They were referred 
for chromosomal microarray testing at the Diagnostic 
Genomics Department, PathWest, WA. Genomic DNA 
was isolated from peripheral blood samples according to 
standard procedures.
2.3 | Microarray analysis
Microarray was performed using an Infinium® 
HumanCytoSNP- 12 BeadChip assay according to manufac-
turer’s instructions (Illumina, San Diego, CA). BeadChips 
were scanned with iScan, with data generated through 
GenomeStudio (Illumina). Analysis was carried out with 
KaryoStudio (v4.1), and only copy number variations 
(CNVs) containing RefSeq genes were interrogated.
2.4 | Bioinformatic analysis
We mined data from The Functional Annotation of Mammalian 
Genomes 5 (FANTOM5), a transcriptomic resource generated 
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from RNA analyzed using Cap Analysis of Gene Expression 
(CAGE) (Consortium et al., 2014). Coordinates for 22q11.2 
were imputed into the resource “FANTOM5 PHASE1 FREEZE 
DPI clusters human (robust)” to identify candidate promoters 
representing mRNA transcripts within this genomic locus. Data 
from normalized tag counts from “FANTOM5 Human CAGE 
Phase1 CTSS- robust cluster filtered (rle, normalized)” were 
extracted to construct graphs representing expression profiles 
for candidate genes (normalized as tags per million (TPM), cal-
culated using the relative log expression (rle). Candidate genes 
were analyzed for their enriched expression in the nervous sys-
tem, identified by a statistical evaluation for their ontological 
classification (UBERON: 0001016). Expression profiles for 
fetal and adult brain structures derived from human donor sam-
ples were also generated for 22q11.2 genes that were enriched 
in nervous system expression libraries.
2.5 | GenBank reference sequences
ZNF74 (NM_001256524.1), KLHL22 (NM_032775.3), 
MED15 (NM_001003891.2), PI4KA (NM_058004.3), 
SERPIND1 (NM_000185.3), CRKL (NM_005207.3), 
AIFM3 (NM_144704.2), SLC7A4 (NM_004173.2), BCRP2 
(NR_037566.1).
3 |  CLINICAL REPORTS
3.1 | Family 1
3.1.1 | Patient 1
Patient 1 is the second child of non consanguineous healthy par-
ents with a history of recurrent miscarriage and first child born 
with bladder exstrophy. Patient 1 was born after an uncompli-
cated pregnancy and delivered by non elective cesarean section 
due to fetal distress. Birthweight was 3,575 g. The parents and 
child health nurse became concerned from about 20 months of 
age because of limited speech and interactions. A diagnosis of 
global developmental delay with autistic features was made at 
2 years 6 months of age, and a formal diagnosis of autism spec-
trum disorder was made at the age of 4 years. At 11 years of age, 
speech included 7–8 word sentences with limited comprehen-
sion and echolalia. Reading skills were approximately at 6- year 
age level, he attended the education support unit and there were 
some behavioral concerns at school. There was no history of sei-
zures. At the time of examination (12 years 6 months), his par-
ents reported him to be very vocal with speech being a relative 
strength. Height was on the 50th percentile, weight was in the 
90th–97th percentile range, and head circumference was on the 
98th percentile. A relatively high forehead with widow’s peak 
was present together with posteriorly rotated prominent ears 
and slightly deep- set eyes with sparse eyebrows and upslanting 
palpebral fissures. Motor stereotypies including hand flapping 
were also present. Microarray analysis identified a paternally 
inherited 22q11.2 duplication, approximately 730Kb in size, in 
the region between LCR22B and LCR22D (chr22:20,733,667-
 21,462,353 GRCh37/hg19 assembly). Patient 1 also had a de 
novo duplication of chromosome 19p13.3, approximately 
340Kb in size, that was not found in his sister, patient 2, and was 
of uncertain clinical significance (chr19:1,451,255- 1,788,247 
GRCh37/hg19 assembly). Conventional chromosome analysis 
and fragile X testing were also performed, and no abnormalities 
were detected.
3.1.2 | Patient 2
Patient 2 is the third child in family 1 and was delivered at 
term by elective lower segment caesarean section (LSCS) and 
weighed 3,060 g. A diagnosis of developmental delay, intel-
lectual impairment, and autism spectrum disorder was made 
at the age of 3 years. Ongoing issues included obsession 
with food and pica as well as significant anxiety. There were 
no reported seizures. At the time of the examination (aged 
10 years and 9 months), height was on the 50th percentile, 
weight was on the 97th percentile, and head circumference 
was on the 98th percentile. She had a relatively tall forehead, 
posteriorly rotated ears, and deep- set eyes. Microarray analy-
sis showed that patient 2 had the same paternally inherited 
22q11.2 duplication identified in her brother. Conventional 
chromosome analysis and fragile X testing were also per-
formed, and no abnormalities were detected.
3.1.3 | Other family members
The asymptomatic father of patients 1 and 2 had the same du-
plication as his children (identified as Patient 3 in our study) 
and a normal male karyotype by conventional chromosome 
analysis. There was no family history of autistic features or 
intellectual disability. Patients 1 and 2 have a brother with 
bladder exstrophy who has not been tested by microarray.
3.2 | Family 2
3.2.1 | Patient 4
Patient 4 was the first child of nonconsanguineous and 
healthy parents born at term. She was first examined by a 
pediatrician aged 4 years 6 months due to severe develop-
mental delay. She was nonverbal and had autism spectrum 
disorder, severe intellectual disability, and epilepsy. Her sei-
zure disorder was comanaged with a neurologist. Her hearing 
was normal. No cardiac or palatal abnormalities were noted, 
and she was not dysmorphic. She had short stature and was 
obese (height 25th percentile and weight >97th percentile). 
At 12 years and 3 months of age, she attended a special school 
for children due to her learning and behavioral problems, 
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which included self- injury. Fragile X testing, MECP2 muta-
tion testing, urine and metabolic screens were all negative, 
and conventional chromosome analysis showed a normal fe-
male karyotype. A cerebral MRI was performed aged 6 years 
6 months with a nonspecific mild increase in flair signal 
noted within the periventricular white matter of both parietal 
lobes. Microarray analysis identified a maternally inherited 
22q11.2 duplication, approximately 120Kb in size, in the 
region between LCR22C and LCR22D (chr22:20,956,906-
 21,075,537 GRCh37/hg19 assembly).
3.2.2 | Patients 5 and 6
Patients 5 and 6 were presumed monozygotic twin boys. 
Placental insufficiency and twin- to- twin transfusion were 
noted during the pregnancy. The neonatal ultrasound find-
ings were normal. The twin boys were born at 32- week gesta-
tion by cesarean section.
3.2.3 | Patient 5
Patient 5 weighed 1800 g at birth. He was first examined by a 
pediatrician aged 18.5 months and was diagnosed with global 
developmental delay The developmental assessment (Huntley, 
1996) gave a corrected age of 16.5 months with limited lan-
guage (age equivalent 9.5 months). He was seen aged 6 years 
6 months and diagnosed with mild intellectual disability (IQ 
score 63, Leiter- R intellectual assessment test) and autism 
spectrum disorder. He had only some phrased speech and 
attended an Educational Support Unit within a mainstream 
school. He had no reported seizures. He had short stature (3rd 
percentile) and was overweight for height (50th - 75th percen-
tile). Microarray analysis identified the same maternally inher-
ited 22q11.2 duplication, as his sister and brother.
3.2.4 | Patient 6
Patient 6 was a presumed monozygotic twin of patient 5 above. 
Patient 6 weighed 1,500 g at birth. He was first examined by a 
pediatrician aged 18.5 months and was diagnosed with global 
developmental delay (Huntley, 1996). He was seen aged 6 years 
6 months, and he was diagnosed with moderate intellectual dis-
ability (IQ score 49, Leiter- R intellectual assessment test) and 
autism spectrum disorder. Language impairment was moderate 
and his adaptive behavior was low. He had short stature and obe-
sity (height 25th percentile, weight 97th percentile). Microarray 
analysis identified the same maternally inherited 22q11.2 dupli-
cation, as his sister and brother.
3.2.5 | Other family members
The asymptomatic mother of patients 4, 5, and 6 had the 
same duplication as her three children and was of normal 
intelligence with short stature and obesity (identified as 
Patient 7 in our study). There was no family history of schiz-
ophrenia or major mental health disorders.
3.3 | Family 3
3.3.1 | Patient 8
Patient 8 was the second of two children born to nonconsan-
guineous parents of Filipino descent. His mother had well- 
controlled gestational diabetes, and he was born at term by 
non elective LSCS for failure to progress. His birthweight was 
3175 g, his length was 51 cm, and his head circumference was 
34 cm. He had speech delay and met DSM IV criteria for a di-
agnosis of high functioning autism in early childhood. He was 
examined at age 12 years by a Clinical Geneticist. Clinical find-
ings included mild facial dysmorphism with slightly upslanting 
palpebral fissures and long luxuriant eyelashes. He was noted 
to have long narrow hands and fingers and relatively long toes. 
His growth was in the normal range with height on the 90th per-
centile, weight between the 50th and 75th percentiles, and head 
circumference on the 75th percentile. Microarray analysis iden-
tified a maternally inherited 22q11.2 duplication, approximately 
400Kb in size, in the region between LCR22C and LCR22D 
(chr22:21,009,596- 21,462,353 GRCh37/hg19 assembly).
3.3.2 | Other family members
The asymptomatic mother of patient 8 had the same duplica-
tion as her son (identified as Patient 9 in our study). There 
was no family history of ASD; however, there is a history 
of mental health issues on the maternal side of the family 
with patient 8’s grandmother (diagnosed with schizophrenia), 
and uncle (diagnosed with a mild psychosis). His sister has 
a history of congenital hydrocephalus, childhood stroke, and 
secondary hemiplegia with mild intellectual disability. The 
sister was not tested by microarray analysis. Further testing 
would be required to clarify the basis of the neuropsychiatric 
differences in this family and a second disorder cannot be 
excluded.
3.4 | Family 4
3.4.1 | Patient 10
Patient 10 was born vaginally at 41- week gestation. He was 
diagnosed with a unilateral cleft lip after birth and has a 
later diagnosis of a submucous cleft palate. Early motor 
milestones were achieved at a normal age; however, he had 
delayed speech and language development thought to be 
secondary to conductive hearing loss that required speech 
therapy intervention. He has some fine motor difficulties 
for which he is seeing an occupational therapist. He has 
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no formal diagnosis of autism, however has some sensory 
processing issues, a high pain threshold and prefers a struc-
tured environment with evidence of mild anxiety if routines 
are altered. When examined by a Clinical Geneticist at age 
5 years 1 month, patient 10 was noted to have a tall forehead, 
almond- shaped eyes and upslanting palpebral fissures, long 
eyelashes, unilateral cleft lip and submucous cleft palate. 
He had broad fingers of average length. Microarray analysis 
identified a maternally inherited 22q11.2 duplication, ap-
proximately 400Kb in size, in the region between LCR22C 
and LCR22D (chr22:21,091,640- 21,462,353 GRCh37/
hg19 assembly).
3.4.2 | Other family members
The mother of patient 10 had the same duplication as her son 
and was asymptomatic (identified as Patient 11).
3.5 | Family 5
3.5.1 | Patient 12
Patient 12 was investigated aged 2 years 9 months by a neurolo-
gist because of involuntary movements and behavioral issues. 
He was found to have complex motor stereotypies, involuntary 
movements, and sleep problems with no evidence of seizures. 
He had macroscopic hematuria, and his kidney ultrasound, 
renal function, copper levels, and urine metabolic screen were 
normal. At 2 years 6 months of age, his height was on the 10th–
25th percentile, weight was on the 50th percentile, and head 
circumference was on the 50th–98th percentile. At 4 years 
and 11 months, he had mood and behavioral issues, and his 
growth was maintaining its previous trajectory with height on 
the 25th percentile and weight on the 50th percentile. By age 
5 years, he was motor age appropriate with no speech or growth 
delay and no intellectual disability. Assessment at age 7 years 
showed development to be within normal limits apart from 
reading skills. He was found to be more emotional than other 
boys of his age and demonstrated motor stereotypies, in par-
ticular hand flapping. At 7 years and 11 months, his weight and 
height were on the 50th percentile and his head circumference 
was on the 75th percentile. He had a normal brain MRI at age 
4 years. Microarray analysis identified a 22q11.2 duplication, 
approximately 400Kb in size, in the region between LCR22C 
and LCR22D. There is insufficient evidence to determine the 
pattern of inheritance for their duplication (chr22:21,091,640-
 21,462,353 GRCh37/hg19 assembly).
3.5.2 | Other family members
There was a family history of anxiety and obsessive–com-
pulsive tendencies. Family members have not been tested for 
the duplication.
3.6 | Family 6
3.6.1 | Patient 13
Patient 13 is the only child of nonconsanguineous parents of 
indigenous origin. The pregnancy was complicated by undiag-
nosed gestational diabetes. He was born at term via spontaneous 
vaginal delivery weighing 3,400 g. He underwent investigations 
for hypotonia at the age of 7 months and had a normal head CT 
at the time. His developmental milestones were delayed, and he 
was subsequently diagnosed with global developmental delay at 
the age of three and a half years. His major difficulties were gross 
motor delay in association with toe walking and speech and lan-
guage delay. Cognitive abilities at the age of 4 years were found 
to be in the borderline range (FSIQ 79, WPPSI III). Some early 
intervention services were accessed in the preschool years. At 
the age of 14 years, there were ongoing issues with motor stereo-
typies, in particular hand movements and pacing, that had been 
present for several years. Furthermore, there were difficulties 
with social interaction, coping with change as well as anxiety. 
On physical examination at 14 years, he was tall (height, weight 
and head circumference on the 98th percentile) with a prominent 
jaw and forehead. He had reduced dorsiflexion in both ankles. 
The child was diagnosed with ASD at 16 years of age and is now 
attending an alternative education program to accommodate his 
needs. Baseline investigations included fragile X studies, growth 
hormone studies, IGF1, and thyroid function testing, all of which 
were unremarkable.
Microarray analysis identified a 22q11.2 duplication, ap-
proximately 400Kb in size, in the region between LCR22C 
and LCR22D (chr22:21,062,271- 21,462,353 GRCh37/hg19 
assembly).
3.6.2 | Other family members
There is no history of developmental difficulties in the imme-
diate family. The duplication was not maternally inherited; 
however, the paternal sample was unavailable for evaluation.
4 |  RESULTS
4.1 | Characterization of atypical nested 
duplications: no correlation between CNV size 
and severity of neurodevelopmental traits
Atypical nested 22q11.2 duplications were identified by 
microarray analysis in 13 individuals from six unrelated 
families and are shown schematically in Figure 1a–b. The 
duplications ranged in size from approximately 120Kb to 
730Kb. Breakpoint positions also differed between families, 
with duplications located between LCR22B and LCR22D 
(B- D) in family 1, LCR22C and LCR22C/D (C- C/D) in fam-
ily 2, and LCR22C/D and LCR22D (C/D- D) in families 3, 
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4, 5, and 6. Not all breakpoints coincided with LCR regions. 
The only other copy number variant identified was a de novo 
duplication of chromosome 19p13.3 in patient 1 that was not 
found in his sister, and had uncertain clinical significance. 
The duplications were found to be inherited in all cases (7/7) 
where both parental samples were available for testing, with 
five maternal and two paternal in origin. Confirmed parental 
carriers were all asymptomatic (families 1, 2, 3, and 4).
Inter- and intra familial variability in phenotypes was 
 observed among the subjects with atypical nested duplica-
tions, ranging from no apparent phenotype in the four parental 
carriers to severe intellectual disability, developmental delay, 
and non verbal autism. Clinical summaries for each patient are 
shown in Table 1. The majority of the individuals (8/13) had 
developmental delay/cognitive impairment with most having 
speech delay and language impairment (7/13). Variability 
in cognitive impairment was found within the same family, 
despite having the same size duplication. Many individuals 
were diagnosed with ASD (7/13 with a formal diagnosis of 
autism, patients 1, 2, 4, 5, 6, 8, 13) or exhibited features con-
sistent with ASD including stereotypical movements (patient 
12) with all symptomatic patients having behavioral prob-
lems. Short stature was noted in the three siblings in family 2 
(patients 4, 5, 6) and their asymptomatic mother. No signifi-
cant dysmorphisms were observed, and there was no consis-
tently recognizable facial phenotype. Patients who consented 
to publication of photographs are shown in Figure 2. A tall 
forehead was noted in four cases (patients 1, 2, 10, 13) and 
upslanting palpebral fissures in three (patients 1, 8, and 10). 
Interestingly, no distinct facial features have been reported 
for the reciprocal atypical nested deletions, but the common 
dysmorphic features included upslanting palpebral fissures 
and a prominent forehead (Burnside, 2015). Hand/foot anom-
alies were found in two cases (patients 8 and 10). Relative 
F I G U R E  1  Schematic representation of chromosome 22. (a) The region of interest is shown by a red box on the ideogram of the 
chromosome. The eight low copy repeat (LCR) sequences located at 22q11.2 are depicted as black boxes (LCR22A- H). Critical genes are shown 
and the central 22q11.2 region located between LCR22B and LCR22D. (b) Schematic representation of chromosome 22 duplications identified in 
patients in this study, reported in the literature and the DECIPHER database (with clinical information and only one CNV). All duplications are 
located between LCR22B and LCR22D and represented by a horizontal blue line. RefSeq genes in the region are shown. Data based on UCSC 
Genome Browser 2009 (GRCh37/hg19) Assembly [http://www.genome.ucsc.edu]
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T A B L E  1  Common clinical features identified in individuals with central 22q11.2 duplications
Details Family 1 Family 2 Family 3 Family 4 Family 5 Family 6
Case No. 1 2 3 4 5 6 7 8 9 10 11 12 13
Sex M F M F M M F M F M F M M
Age at last 
evaluation
12 years 6 months 10 years 
9 months
12 years 3 months 6 years 6 months 6 years 6 months 16 years 5 years 1 months 7 years 11 months 14 years
Duplication 
size (Kb)
730 730 730 120 120 120 120 400 400 400 400 400 400
Duplication 
breakpoints
B to D B to D B to D C to D C to D C to D C to D C to D C to D C to D C to D C to D C to D
Location 
(hg19)
chr22:20,733,667- 21,462,353 chr22:20,956,906- 21,075,537 chr22:21,009,596- 21,462,353 chr22:21,091,640- 21,462,353 chr22:21,091,640-
 21,462,353
chr22:21,062,271-
 21,462,353
Other CNVs 
of possible 
significance
De novo 19p13.3 
duplication
_ _ _ _ _ _ _ _ _ _ _ _
Inheritance Paternal Paternal Unknown Maternal Maternal Maternal Unknown Maternal Unknown Maternal _ Unknown Unknown
Development 
delay and/or 
cognitive 
impairment
Severe global 
developmental 
delay, intellectual 
disability
Developmental 
delay, 
intellectual 
disability
_ Severe intellectual 
disability, severe 
developmental 
delay,
Global develop-
mental delay, 
moderate 
intellectual 
disability
Global developmental 
 delay, mild 
 Intellectual disability
_ Speech delay _ Early speech and 
language delay, fine 
motor difficulties
_ _ Global developmental 
delay, borderline IQ 
age 4 years
Psychiatric/
Behavior 
problems
ASD, motor 
stereotypies
ASD, anxiety _ Severe ASD, 
nonverbal at 
12 years, 
self- injury
ASD, moderate 
language 
impairment
ASD, moderate  
language impairment
_ High 
functioning 
ASD
_ Behavioral issues as 
prefers structure, 
anxiety with 
changes in routine 
(currently no formal 
diagnosis of ASD)
_ Complex motor 
stereotypies with 
repetitive jumping, 
hand flapping, 
clenching of hands 
and face. Mood 
issues
ASD, variable motor 
stereotypies: hand 
movements, pacing, 
toe walking. Anxious, 
difficulties with 
social interaction
Palatal defects _ _ _ _ _ _ _ _ _ Unilateral cleft lip 
and submucous 
cleft palate
_ _ _
Hearing 
impairment
_ _ _ _ _ _ _ _ _ Conductive hearing 
loss
_ _ _
Growth delay _ _ _ Short stature Short stature Short stature Short stature _ _ _ _ _ _
Macrocephaly Relative macro-
cephaly (head 
circumference 
98th percentile)
Relative 
macrocephaly 
(head 
circumference 
98th percentile)
_ _ _ _ _ _ _ _ _ _ _
Microcephaly _ _ _ _ _ _ _ _ _ _ _ _ _
Hypotonia _ _ _ _ _ _ _ _ _ _ _ _ Hypotonia at 7 months 
of age
Seizures _ _ _ Epilepsy _ _ _ _ _ _ _ _ _
Heart defect _ _ _ _ _ _ _ _ _ _ _ _ _
Urogenital 
anomaly
_ _ _ _ _ _ _ _ _ _ _ Macroscopic 
hematuria. Kidney 
ultrasound normal
_
Dysmorphism Tall forehead, 
posteriorly rotated 
prominent ears, 
slightly deep- set 
eyes, upslanting 
palpebral fissures
Tall forehead, 
posteriorly 
rotated ears, 
deep- set eyes
_ _ _ _ _ Long 
luxuriant 
eyelashes, 
upslanting 
palpebral 
fissures
_ Tall forehead, 
almond- shaped 
eyes, long 
eyelashes, 
upslanting palpebral 
fissures
_ _ Tall forehead and 
prominent jaw
(Continues)
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T A B L E  1  Common clinical features identified in individuals with central 22q11.2 duplications
Details Family 1 Family 2 Family 3 Family 4 Family 5 Family 6
Case No. 1 2 3 4 5 6 7 8 9 10 11 12 13
Sex M F M F M M F M F M F M M
Age at last 
evaluation
12 years 6 months 10 years 
9 months
12 years 3 months 6 years 6 months 6 years 6 months 16 years 5 years 1 months 7 years 11 months 14 years
Duplication 
size (Kb)
730 730 730 120 120 120 120 400 400 400 400 400 400
Duplication 
breakpoints
B to D B to D B to D C to D C to D C to D C to D C to D C to D C to D C to D C to D C to D
Location 
(hg19)
chr22:20,733,667- 21,462,353 chr22:20,956,906- 21,075,537 chr22:21,009,596- 21,462,353 chr22:21,091,640- 21,462,353 chr22:21,091,640-
 21,462,353
chr22:21,062,271-
 21,462,353
Other CNVs 
of possible 
significance
De novo 19p13.3 
duplication
_ _ _ _ _ _ _ _ _ _ _ _
Inheritance Paternal Paternal Unknown Maternal Maternal Maternal Unknown Maternal Unknown Maternal _ Unknown Unknown
Development 
delay and/or 
cognitive 
impairment
Severe global 
developmental 
delay, intellectual 
disability
Developmental 
delay, 
intellectual 
disability
_ Severe intellectual 
disability, severe 
developmental 
delay,
Global develop-
mental delay, 
moderate 
intellectual 
disability
Global developmental 
 delay, mild 
 Intellectual disability
_ Speech delay _ Early speech and 
language delay, fine 
motor difficulties
_ _ Global developmental 
delay, borderline IQ 
age 4 years
Psychiatric/
Behavior 
problems
ASD, motor 
stereotypies
ASD, anxiety _ Severe ASD, 
nonverbal at 
12 years, 
self- injury
ASD, moderate 
language 
impairment
ASD, moderate  
language impairment
_ High 
functioning 
ASD
_ Behavioral issues as 
prefers structure, 
anxiety with 
changes in routine 
(currently no formal 
diagnosis of ASD)
_ Complex motor 
stereotypies with 
repetitive jumping, 
hand flapping, 
clenching of hands 
and face. Mood 
issues
ASD, variable motor 
stereotypies: hand 
movements, pacing, 
toe walking. Anxious, 
difficulties with 
social interaction
Palatal defects _ _ _ _ _ _ _ _ _ Unilateral cleft lip 
and submucous 
cleft palate
_ _ _
Hearing 
impairment
_ _ _ _ _ _ _ _ _ Conductive hearing 
loss
_ _ _
Growth delay _ _ _ Short stature Short stature Short stature Short stature _ _ _ _ _ _
Macrocephaly Relative macro-
cephaly (head 
circumference 
98th percentile)
Relative 
macrocephaly 
(head 
circumference 
98th percentile)
_ _ _ _ _ _ _ _ _ _ _
Microcephaly _ _ _ _ _ _ _ _ _ _ _ _ _
Hypotonia _ _ _ _ _ _ _ _ _ _ _ _ Hypotonia at 7 months 
of age
Seizures _ _ _ Epilepsy _ _ _ _ _ _ _ _ _
Heart defect _ _ _ _ _ _ _ _ _ _ _ _ _
Urogenital 
anomaly
_ _ _ _ _ _ _ _ _ _ _ Macroscopic 
hematuria. Kidney 
ultrasound normal
_
Dysmorphism Tall forehead, 
posteriorly rotated 
prominent ears, 
slightly deep- set 
eyes, upslanting 
palpebral fissures
Tall forehead, 
posteriorly 
rotated ears, 
deep- set eyes
_ _ _ _ _ Long 
luxuriant 
eyelashes, 
upslanting 
palpebral 
fissures
_ Tall forehead, 
almond- shaped 
eyes, long 
eyelashes, 
upslanting palpebral 
fissures
_ _ Tall forehead and 
prominent jaw
(Continues)
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macrocephaly was noted in two siblings in family 1 (patients 
1 and 2). Seizures were uncommon (1/13, observed only in 
patient 4), and no gross abnormalities were reported on brain 
MRI in all cases examined (data not shown). Palatal defects 
were also uncommon (1/13, patient 10). Notably, none of our 
subjects were diagnosed with congenital heart defects.
There was no correlation between size of atypical nested 
duplication and severity of intellectual disability or develop-
mental delay (see Table 1) in symptomatic individuals. The 
duplication detected in family 2 was the smallest among the 
patients presented herein (120Kb) and those previously re-
ported. Intrafamilial variability in phenotypes was noted in 
this family with patient 4 having severe nonverbal ASD, se-
vere intellectual disability, and severe global developmental 
delay, while her twin brothers (patients 5 and 6) had mild 
and moderate intellectual disability and language impair-
ment and her mother was clinically unaffected. It is notewor-
thy that placental insufficiency and twin- to- twin transfusion 
for patients 5 and 6 occurred during pregnancy and represent 
a significant confound and possible explanation for pheno-
typic variability with their sister, patient 4. Nevertheless, 
in all four individuals from family 2, the PI4KA gene was 
the only gene included in the duplicated region and this in-
volved a partial duplication at the 3’ end of the gene. It is 
possible that this partial duplication may disrupt the nor-
mal copy of the gene on this allele. The functional effect 
of this duplication and the clinical significance is currently 
unclear. Mutations in PI4KA have recently been linked to an 
F I G U R E  2  Photographs of patients with central 22q11.2 duplications showing that there is no recognizable facial phenotype. Patient 1 aged 
12 years and his sister aged 10 years who have a duplication between LCR22B and LCR22D. Patient 10 aged 5 years who also has a duplication 
between LCR22C and LCR22D. Patient 12 aged 7 years and 11 months has a duplication in LCR22C and LCR22D. Patient 8 aged 12 years and his 
asymptomatic mother patient 9 who both have a duplication between LCR22C and LCR22D
Details Family 1 Family 2 Family 3 Family 4 Family 5 Family 6
Hand/foot 
anomalies
_ _ _ _ _ _ _ Long narrow 
hands and 
fingers, 
relatively 
long toes
_ Broad fingers 
(average length)
_ _ _
Brain Imaging _ _ _ Brain MRI with 
no significant 
anomalies 
identified
Neonatal ultra-
sound with no 
anomalies 
detected
Neonatal ultrasound 
 with no anomalies 
 detected
_ _ _ _ _ Brain MRI with no 
anomalies 
identified
Head CT scan at 
7 months of age with 
no anomalies detected
Other features _ _ Asymptomatic Obese _ Obese Asymptomatic, 
obese
_ Asymptomatic _ Asymptomatic _ Reduced dorsiflexion 
in both ankles
A “- ” sign indicates features which were not present or not detected.
T A B L E  1  (Continued)
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autosomal recessively inherited neuronal migration disorder 
(Pagnamenta et al., 2015). Although the family do not have 
another CNV, the presence of another genetic modifier or a 
second disorder cannot be excluded, and so further workup 
is needed to establish the underlying cause for severe fea-
tures observed in patient 4.
4.2 | Genotype–phenotype comparison for 
symptomatic subjects with atypical nested 
duplications vs. typical proximal duplications
We investigated the possibility that the clinical features 
of subjects with atypical nested (LCR22B- LCR22D) du-
plications might be distinct from subjects with typical 
proximal duplications (A- D). We compared the clinical 
phenotypes of the nine symptomatic individuals in this 
study with other known atypical nested duplications (six 
previously reported and 11 cases in the DECIPHER da-
tabase with clinical details and only one CNV present 
(https://decipher.sanger.ac.uk) (see Supporting informa-
tion Table S1). These atypical nested 22q11.2 duplica-
tions (n = 26) were then compared to a study of typical 
22q11.2 duplications (n = 37) (see Table 1) (Wenger 
et al., 2016) and led to the following findings. Firstly, we 
observed that the majority of both duplications were in-
herited, with only one nested duplication (case #318771 
of DECIPHER) reported to be de novo. Secondly, we 
found a relatively high frequency of developmental delay/
cognitive impairment in the atypical nested 22q11.2 du-
plication cases (81%), a finding which is consistent with 
a previous study of the larger typical duplication cases 
(Wentzel et al., 2008). Interestingly, the incidence of ASD 
and behavioral problems associated with nested atypical 
duplication in all duplication carriers (asymptomatic par-
ents and their symptomatic children) in our study is 46% 
(6/13), which is consistent with autism as a feature of 
22q11.2 typical duplication carriers. However, our small 
sample size and reporting bias represent significant con-
founds in our estimation. Thus, we calculated the inci-
dence of ASD in symptomatic individuals in our study 
together with those reported in the literature and from the 
DECIPHER database to observe a prevalence rate of 31% 
(8/26; see Table 2), including two DECIPHER patients 
(#249936 and #276067). Our finding is in agreement with 
estimated rates of 14%–25% for ASD diagnosis in symp-
tomatic individuals with a typical duplication (Wenger 
et al., 2016).
The incidence of seizures was not appreciably differ-
ent between atypical (15%) and typical duplications (19%) 
(Wenger et al., 2016). In contrast, we observed reductions in 
the frequency of association with hypotonia (8% atypical vs. 
27% typical) and hearing impairment (4% vs. 16%) (Wenger 
et al., 2016). We found that nested duplications in this study 
were not associated with congenital heart disease, although 
there are two such cases reported in DECIPHER (#280410 
and #278381). Despite this, nested duplications remain less 
frequently associated with congenital heart defects when 
compared to typical A- D duplications (8% atypical nested 
vs. 24% typical) (Wenger et al., 2016); however, we ac-
knowledge that our results are based on a small sample size. 
Nevertheless, this observation suggests that nested atypical 
duplications could present with reduced penetrance for sig-
nificant clinical phenotypes such as cardiac defects, hypo-
tonia, and hearing impairment when compared to the larger 
typical duplications. It is interesting to note that this is not 
the case for the incidence of neurodevelopmental traits, 
which are relatively prevalent for both typical and atypical 
nested cases. This is supported by a recent report describing 
similar rates of ASD in individuals with typical duplica-
tions and atypical nested duplications B- D (Clements et al., 
2017). Therefore, it is plausible that the critical genes as-
sociated with these neurodevelopmental phenotypes includ-
ing ASD may be located within the nested region between 
LCR22B and LCR22D.
Details Family 1 Family 2 Family 3 Family 4 Family 5 Family 6
Hand/foot 
anomalies
_ _ _ _ _ _ _ Long narrow 
hands and 
fingers, 
relatively 
long toes
_ Broad fingers 
(average length)
_ _ _
Brain Imaging _ _ _ Brain MRI with 
no significant 
anomalies 
identified
Neonatal ultra-
sound with no 
anomalies 
detected
Neonatal ultrasound 
 with no anomalies 
 detected
_ _ _ _ _ Brain MRI with no 
anomalies 
identified
Head CT scan at 
7 months of age with 
no anomalies detected
Other features _ _ Asymptomatic Obese _ Obese Asymptomatic, 
obese
_ Asymptomatic _ Asymptomatic _ Reduced dorsiflexion 
in both ankles
A “- ” sign indicates features which were not present or not detected.
T A B L E  1  (Continued)
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4.3 | Identification of genes enriched in the 
nervous system that are located within the 
nested LCR22B to LCR22D region
We hypothesized that genes within the nested duplication re-
gion may be relevant to brain development and ASD traits. 
Fourteen RefSeq genes lay within LCR22B- LCR22D, with 
four genes located in the LCR22B- LCR22C region including 
ZNF74 (zinc finger protein 74) (OMIM:194548), SCARF2 
(scavenger receptor class F member 2) (OMIM:613619), 
KLHL22 (kelch- like family member 22) (OMIM:616262), 
and MED15 (mediator complex subunit 15) (OMIM:607372), 
while 10 genes encompassed in the LCR22C- LCR22D region 
including PI4KA (phosphatidylinositol 4- kinase, catalytic, 
alpha), SERPIND1 (serpin peptidase inhibitor, clade D (hepa-
rin cofactor), member 1), SNAP29 (synaptosomal- associated 
protein, 29 kDa) (OMIM:142360), CRKL (v- crk avian sar-
coma virus CT10 oncogene homolog- like) (OMIM:602007), 
AIFM3 (apoptosis inducing factor, mitochondria associated 
3) (OMIM:617298), LZTR1 (leucine- zipper- like transcrip-
tion regulator 1) (OMIM:600574), THAP7 (THAP domain 
containing 7) (OMIM:609518), P2RX6 (purinergic receptor 
P2RX6) (OMIM:608077), SLC7A4 (solute carrier family 7 
member 4) (OMIM:603752), and LRRC74 (leucine- rich re-
peat containing 74B) (Figure 3a).
We sought evidence for the expression of 22q11.2 
genes in tissues of the nervous system, particularly those 
within the LCR22B- LCR22D interval. We surveyed the 
gene expression database FANTOM5 to identify cen-
tral 22q11.2 genes which were significantly enriched in 
expression within the nervous system, identified with 
the UBERON (Dahdul et al., 2012) classification term 
UBERON:0001016. Through this approach, we iden-
tified nine genes (ZNF74, KLHL22, MED15, PI4KA, 
SERPIND1, CRKL, AIFM3, SLC7A4, and BCRP2) which 
were enriched in the nervous system. Furthermore, each of 
these nine genes displayed distinct patterns of expression 
(Figure 3b). For example, mRNA transcripts for ZNF74 
and KHLH22 were more abundant in fetal vs. adult tissue. 
Conversely, PI4KA and AIFM3 were more prominently 
expressed in adult brain tissues. Genes such as CRKL and 
MED15 displayed relatively constant levels of expression 
across fetal and brain tissues. In contrast, SERPIND1, 
SLC7A4, and BCRP2 are very weakly expressed in brain 
tissues. Notably, PI4KA is among the most highly ex-
pressed genes within this interval and is prominently de-
tected in fetal and adult brain, with particularly high levels 
in adult cerebral cortical tissues. In contrast, SERPIND1 
is less attractive as a candidate gene as it is very weakly 
expressed in brain tissues.
5 |  DISCUSSION
Our study reinforces the notion that atypical nested 22q11.2 
duplications are associated with a broad phenotypic spectrum, 
T A B L E  2  Comparison of clinical features in atypical central 22q11.2 duplications and typical proximal duplications
Type of duplication Central 22q11.2 duplications (B- D)
Proximal 22q11.2 
duplications (A- D)
Cohort of symptomatic patients This study (n = 9, 6 
families)
Literature 
(n = 6)
Decipher 
(n = 11)
TOTAL (n = 26) Wenger et al. (2016) 
(n = 37)
Inherited 7/7 tested 4/4 tested 8/9 19/20 inherited (95%)
De novo 0 0 1 1/20 (5%)
Development delay and/or 
cognitive impairment
8 3 10 21/26 (81%)
Psychiatric/Behavior problems 9 0 3 12/26 (46%)
ASD 7 0 2 9/26 (35%) 14%–25%
Palatal defects 1 2 0 3/26 (12%)
Hearing impairment 1 0 0 1/26 (4%) 6/37 (16%)
Growth delay 3 1 2 6/26 (23%)
Hypotonia 1 1 0 2/26 (8%) 10/37 (27%)
Seizures 1 0 3 4/26 (15%) 7/37 (19%)
Heart defect 0 0 2 2/26 (8%) 9/37 (24%)
Urogenital anomaly 0 1 1 2/26 (8%)
Only symptomatic individuals are included in this table. Central duplications cases included those between LCR22B and LCR22D described in this study, published in 
the literature (Diehl et al., 2015; Fan et al., 2007; Fernandez et al., 2009; Ou et al., 2008; Pebrel- Richard et al., 2012; Tucker et al., 2014) and within the DECIPHER 
database with clinical information and one CNV (https://decipher.sanger.ac.uk). Typical proximal duplication cases included those 3 Mb in size between LCR22A and 
LCR22D (Wenger et al., 2016).
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ranging from clinically normal to severe developmental delay 
with profound intellectual disability. We confirm incomplete 
penetrance and no association between duplication size and 
clinical severity; the family with the smallest duplication de-
scribed to date includes patients with the most severe clini-
cal presentation. We acknowledge that there is ascertainment 
bias in the identification of atypical duplications in this group 
of patients. However, it is likely that cases of nested 22q11.2 
duplications with significant and profound neurocognitive 
disorders are a consequence of additional causative factor(s) 
that augment the severity of the clinical phenotypes, and 
thus in these settings, great caution should be applied when 
considering nested duplications as the sole or even predomi-
nant contributing factor. What is clear is that while typical 
22q11.2 duplication carriers show elevated (14%–25%) rates 
of ASD (Wenger et al., 2016), a significant number of in-
dividuals show no signs of ASD or related developmental 
concerns. Thus, while we cannot rule out the possibility 
that nested atypical duplications represent a benign variant, 
our study supports the notion that atypical nested 22q11.2 
LCR22B- LCR22D duplications are associated with an in-
creased risk for neurodevelopmental phenotypes particularly 
ASD. Furthermore, our conclusion is consistent with a recent 
study reporting that the incidence of ASD is similar in both 
typical and the nested atypical duplication cases, further sug-
gesting that the nested duplication and its genes constitute 
the minimal interval which is relevant to neurodevelopmental 
phenotypes including ASD (Clements et al., 2017).
In highlighting our patients harboring 22q11.2 duplica-
tions (LCR22B- LCR22D) nested within the typical 22q11.2 
F I G U R E  3  Identification of neuronal genes within 22q11.2 LCR22B to LCR22D. (a) Analysis of 22q11.2 genes 
(hg19:chr22:20733667- 21462353) with FANTOM5. Of the 88 CAGE defined promoters within 22q11.2, 23 promoters showed significant 
enrichment for expression in “nervous system”- related samples (sample ontology enrichment analysis). Genes enriched in the nervous system 
(highlighted in red) are identified by the UBERON anatomical term “nervous system.” Where available, Haploinsufficiency Index (%HI) scores 
are provided as an indication of the potential deleterious effect of candidate gene loss. (b) Heat map representing expression levels for ZNF74 
(NM_001256524.1), KLHL22 (NM_032775.3), MED15 (NM_001003891.2), PI4KA (NM_058004.3), SERPIND1 (NM_000185.3), CRKL 
(NM_005207.3), AIFM3 (NM_144704.2), SLC7A4 (NM_004173.2), BCRP2 (NR_037566.1). Data from normalized tag counts from “FANTOM5 
Human CAGE Phase1 CTSS- robust cluster filtered (rle, normalized)” were extracted to construct graphs representing expression profiles for 
candidate genes (normalized as tags per million (TPM), calculated using the relative log expression (rle). Gene expression profiles data are provided 
in Supporting information Table S2
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region (LCR22A- LCR22D), our aims were to expand the 
reported 22q11.2 phenotypic spectrum as well as investi-
gate candidate genes that may be associated with distinct 
clinical features. We found that common symptoms asso-
ciated with atypical central 22q11.2 duplications include 
developmental delay/cognitive impairment, autism spec-
trum disorder, and behavioral problems, thereby suggest-
ing that candidate gene(s) for such neurological traits may 
be located in the nested LCR22B- LCR22D interval. When 
the gene content of the central region was analyzed using 
FANTOM5, several candidates for neurodevelopmental 
phenotypes, including PI4KA and AIFM3, were found to 
be enriched in the nervous system. PI4KA has been asso-
ciated with schizophrenia susceptibility (Vorstman et al., 
2009). Also, compound heterozygous mutations in the 
PI4KA gene were identified in tissue samples from three 
fetuses with multiple congenital abnormalities, conceived 
by unrelated parents of European descent, with perisylvian 
polymicrogyria (PMG), cerebellar hypoplasia, and arthro-
gryposis (Pagnamenta et al., 2015). Interestingly, PI4KA 
was included in the duplicated regions of all the families 
presented, either completely or partially, and it was the only 
gene located within the duplicated region in one family 
with three severely affected individuals and an asymptom-
atic carrier mother. Thus, our analysis implicates a role for 
the PI4KA gene to underlie ASD traits, and prioritizes this 
gene for further study in brain development.
In contrast to the prevalence of developmental delay/cog-
nitive impairment, autism spectrum disorder, and behavioral 
problems in our subjects, we found no incidence of cardiac 
defects in any of our symptomatic patients with central du-
plications. We therefore postulate that the responsible genes 
for cardiac defects are likely to lie beyond the LCR22B to 
LCR22D interval. Of note, TBX1 is a well- characterized 
gene within the LCR22A- LCR22D interval that has a criti-
cal role in the abnormal phenotype associated with 22q11.2 
genomic disorders (Liao et al., 2004; Vitelli, Morishima, 
Taddei, Lindsay, & Baldini, 2002; Yagi et al., 2003), espe-
cially the cardiac defects, and lies upstream of the LCR22B 
to LCR22D interval. Given that significantly fewer of our 
subjects presented with cleft palate, hypotonia, and hearing 
impairment, it is plausible that the responsible genes for such 
factors may also lie beyond the central LCR22B to LCR22D 
interval.
The variable expressivity and incomplete penetrance ob-
served in this study are a common finding with CNVs asso-
ciated with neurodevelopmental disorders, and the underlying 
mechanisms are not well understood (Vorstman et al., 2009). 
Genetic background, modifier genes, epigenetic changes, and 
environmental factors may have an important role. Another 
factor that has been reported to influence the penetrance of 
CNVs, in particular for the expression of intellectual impair-
ment in 22q11.2 deletion patients, is the level of parental 
intelligence (Klaassen et al., 2016). Given that environmental 
factors are important during early childhood but become less 
significant over time, inherited genetic factors associated with 
higher levels of education were proposed to modulate cogni-
tive outcome and explain the variable penetrance (Klaassen 
et al., 2016). While such issues were not formally assessed in 
our study, the impact of environmental factors as well as addi-
tional genetic mutations contributing to neurodevelopmental 
traits in 22q11.2 duplication carriers remains to be clarified.
Variability in expressivity of recurrent CNVs can also 
be explained by a two- hit hypothesis and the presence of a 
second modifying aberration (Aggarwal & Morrow, 2008; 
Girirajan et al., 2010, 2012; Li, Tekin, Buch, & Fan, 2012). 
It has been suggested that CNVs outside the 22q11.2 re-
gion may include genes that modify risk for heart defects 
in some patients with 22q11 deletion syndrome (Mlynarski 
et al., 2016). Although only patient 1 in this study had 
an additional CNV identified, we cannot exclude the co- 
existence of other mutations or CNVs that may directly 
influence the interpretation of results. Patient 1 also had a 
chromosome 19p13.3 duplication. This region of 19p13.3 
contains a number of genes, and a deletion of this region 
has been implicated in a neurodevelopmental phenotype 
(Palumbo et al., 2016). Currently, there is no evidence to 
suggest that the 19p13.3 duplication is clinically signifi-
cant and that the involved genes are triplosensitive; fur-
thermore, this patient did not have a significantly more 
severe phenotype than his younger sister (patient 2), who 
did not have the 19p13.3 duplication. In another case, a 
patient is described with a central 22q11.2 duplication al-
ready recognized to have more than one genetic aberration 
(Diehl et al., 2015). This 3- year- old female patient had an 
additional missense mutation in the SALL4 gene and pre-
sented with normal cognition and multiple skeletal anom-
alies, including left radioulnar synostosis, thumb aplasia, 
rib abnormalities, hypoplasia of the humeral and femoral 
epiphyses, and butterfly vertebrae. Interestingly, these 
skeletal abnormalities had not previously been associated 
with SALL4 mutations or 22q11.2 duplications. Additional 
pathogenic mutations contributing to the severity of the 
neurodevelopmental phenotypes in 22q11.2 duplication 
carriers have to be considered. Demily and colleagues de-
scribed two patients with distal 22q11.2 duplications and 
severe clinical presentations explained by additional patho-
genic mutations (Demily et al., 2018). We cannot exclude 
this possibility and further work is required, particularly 
for those individuals with the more severe phenotypes.
6 |  CONCLUSION
This study extends the phenotypic spectrum of nested atyp-
ical 22q11.2 duplications between LCR22B and LCR22D 
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with variable expressivity and an association with neu-
rodevelopmental phenotypes including autism spectrum 
disorder and behavioral problems. In addition, we have an-
alyzed the gene content of the region LCR22B- LCR22D to 
identify multiple genes which are highly expressed in the 
nervous system, and prioritize PI4KA as a candidate gene 
important to neuronal development. Furthermore, we find 
that atypical nested 22q11.2 duplications show incomplete 
penetrance, consistent with the notion that additional path-
ological mechanisms or genetic factors likely modulate or 
may even explain their clinical presentation in some cases.
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